nodes	percent_of_prediction	percent_of_DWPC	metapath
Estradiol—NR1I2—Docetaxel—skin cancer	0.0746	0.107	CbGbCtD
Estradiol—ABCC10—Docetaxel—skin cancer	0.0524	0.0753	CbGbCtD
Estradiol—ABCG2—Vismodegib—skin cancer	0.0499	0.0718	CbGbCtD
Estradiol—ABCG2—Vemurafenib—skin cancer	0.0394	0.0567	CbGbCtD
Estradiol—ALB—Vismodegib—skin cancer	0.0344	0.0495	CbGbCtD
Estradiol—CYP1A2—Imiquimod—skin cancer	0.0297	0.0427	CbGbCtD
Estradiol—SLCO1B3—Docetaxel—skin cancer	0.0292	0.0421	CbGbCtD
Estradiol—CYP1B1—Docetaxel—skin cancer	0.0285	0.0409	CbGbCtD
Estradiol—CYP1A1—Dacarbazine—skin cancer	0.0279	0.0401	CbGbCtD
Estradiol—ALB—Vemurafenib—skin cancer	0.0272	0.0391	CbGbCtD
Estradiol—CYP2C8—Vismodegib—skin cancer	0.0266	0.0382	CbGbCtD
Estradiol—ABCG2—Dactinomycin—skin cancer	0.0262	0.0377	CbGbCtD
Estradiol—CYP2C19—Vismodegib—skin cancer	0.0223	0.0321	CbGbCtD
Estradiol—CYP2C9—Vismodegib—skin cancer	0.0185	0.0267	CbGbCtD
Estradiol—ABCB1—Vismodegib—skin cancer	0.018	0.0259	CbGbCtD
Estradiol—ABCG2—Fluorouracil—skin cancer	0.0177	0.0255	CbGbCtD
Estradiol—CYP1A2—Vemurafenib—skin cancer	0.0163	0.0234	CbGbCtD
Estradiol—CYP3A4—Imiquimod—skin cancer	0.0155	0.0224	CbGbCtD
Estradiol—CYP3A4—Temozolomide—skin cancer	0.0155	0.0224	CbGbCtD
Estradiol—ABCG2—Docetaxel—skin cancer	0.0135	0.0195	CbGbCtD
Estradiol—CYP1A2—Dacarbazine—skin cancer	0.0125	0.0179	CbGbCtD
Estradiol—ALB—Fluorouracil—skin cancer	0.0122	0.0176	CbGbCtD
Estradiol—CYP3A4—Vismodegib—skin cancer	0.0108	0.0155	CbGbCtD
Estradiol—CYP3A7—Docetaxel—skin cancer	0.00999	0.0144	CbGbCtD
Estradiol—CYP3A7-CYP3A51P—Docetaxel—skin cancer	0.00999	0.0144	CbGbCtD
Estradiol—ABCB1—Dactinomycin—skin cancer	0.00945	0.0136	CbGbCtD
Estradiol—CYP2C8—Fluorouracil—skin cancer	0.00944	0.0136	CbGbCtD
Estradiol—CYP3A4—Vemurafenib—skin cancer	0.00852	0.0123	CbGbCtD
Estradiol—CYP3A5—Docetaxel—skin cancer	0.00749	0.0108	CbGbCtD
Estradiol—CYP1A2—Fluorouracil—skin cancer	0.0073	0.0105	CbGbCtD
Estradiol—CYP2C9—Fluorouracil—skin cancer	0.00658	0.00947	CbGbCtD
Estradiol—AR—scrotum—skin cancer	0.00542	0.0889	CbGeAlD
Estradiol—ABCB1—Docetaxel—skin cancer	0.00488	0.00702	CbGbCtD
Estradiol—CYP3A4—Docetaxel—skin cancer	0.00292	0.0042	CbGbCtD
Estradiol—SHBG—hindlimb—skin cancer	0.00257	0.0422	CbGeAlD
Estradiol—AR—penis—skin cancer	0.00245	0.0401	CbGeAlD
Estradiol—FABP2—epithelium—skin cancer	0.00243	0.0399	CbGeAlD
Estradiol—ESRRB—female reproductive system—skin cancer	0.00238	0.0391	CbGeAlD
Estradiol—GPER1—female reproductive system—skin cancer	0.00164	0.0269	CbGeAlD
Estradiol—ESRRA—nipple—skin cancer	0.00152	0.025	CbGeAlD
Estradiol—GPER1—head—skin cancer	0.00137	0.0224	CbGeAlD
Estradiol—NR1I2—head—skin cancer	0.00114	0.0188	CbGeAlD
Estradiol—FABP2—lymph node—skin cancer	0.00106	0.0173	CbGeAlD
Estradiol—SLCO4A1—nipple—skin cancer	0.00103	0.0169	CbGeAlD
Estradiol—CYP1B1—hair follicle—skin cancer	0.000993	0.0163	CbGeAlD
Estradiol—CYP1A1—skin epidermis—skin cancer	0.000984	0.0161	CbGeAlD
Estradiol—GPER1—lymph node—skin cancer	0.000958	0.0157	CbGeAlD
Estradiol—ESR2—neck—skin cancer	0.000904	0.0148	CbGeAlD
Estradiol—ESRRA—mammalian vulva—skin cancer	0.000889	0.0146	CbGeAlD
Estradiol—AOX1—nipple—skin cancer	0.00088	0.0144	CbGeAlD
Estradiol—SHBG—neck—skin cancer	0.000879	0.0144	CbGeAlD
Estradiol—ESR1—blood vessel—skin cancer	0.000866	0.0142	CbGeAlD
Estradiol—ABCC10—nipple—skin cancer	0.000856	0.014	CbGeAlD
Estradiol—ESRRA—female reproductive system—skin cancer	0.000762	0.0125	CbGeAlD
Estradiol—SLC22A3—nipple—skin cancer	0.000732	0.012	CbGeAlD
Estradiol—ESR2—connective tissue—skin cancer	0.000648	0.0106	CbGeAlD
Estradiol—AR—nipple—skin cancer	0.000638	0.0105	CbGeAlD
Estradiol—ESRRA—head—skin cancer	0.000636	0.0104	CbGeAlD
Estradiol—SHBG—connective tissue—skin cancer	0.00063	0.0103	CbGeAlD
Estradiol—SLC22A11—female reproductive system—skin cancer	0.000625	0.0102	CbGeAlD
Estradiol—ESR1—neck—skin cancer	0.000619	0.0102	CbGeAlD
Estradiol—ESR2—epithelium—skin cancer	0.000615	0.0101	CbGeAlD
Estradiol—SLCO4A1—mammalian vulva—skin cancer	0.000602	0.00987	CbGeAlD
Estradiol—SLCO1C1—head—skin cancer	0.000537	0.00881	CbGeAlD
Estradiol—SLC22A3—connective tissue—skin cancer	0.000519	0.00852	CbGeAlD
Estradiol—SLCO4A1—female reproductive system—skin cancer	0.000515	0.00845	CbGeAlD
Estradiol—AOX1—mammalian vulva—skin cancer	0.000514	0.00842	CbGeAlD
Estradiol—ABCC10—mammalian vulva—skin cancer	0.0005	0.0082	CbGeAlD
Estradiol—CYP1A2—nipple—skin cancer	0.000482	0.00791	CbGeAlD
Estradiol—CYP1B1—connective tissue—skin cancer	0.000477	0.00783	CbGeAlD
Estradiol—CYP1A1—nipple—skin cancer	0.000476	0.0078	CbGeAlD
Estradiol—ESR2—lymphoid tissue—skin cancer	0.000474	0.00777	CbGeAlD
Estradiol—ESR2—female reproductive system—skin cancer	0.000457	0.00749	CbGeAlD
Estradiol—SLCO1B1—female reproductive system—skin cancer	0.000454	0.00744	CbGeAlD
Estradiol—AR—connective tissue—skin cancer	0.000452	0.00741	CbGeAlD
Estradiol—ESRRA—lymph node—skin cancer	0.000445	0.0073	CbGeAlD
Estradiol—SHBG—female reproductive system—skin cancer	0.000444	0.00728	CbGeAlD
Estradiol—ABCC10—lymphoid tissue—skin cancer	0.000444	0.00728	CbGeAlD
Estradiol—ESR1—connective tissue—skin cancer	0.000444	0.00728	CbGeAlD
Estradiol—AOX1—female reproductive system—skin cancer	0.00044	0.00721	CbGeAlD
Estradiol—CYP1B1—skin of body—skin cancer	0.000431	0.00707	CbGeAlD
Estradiol—SLCO4A1—head—skin cancer	0.000431	0.00706	CbGeAlD
Estradiol—AR—epithelium—skin cancer	0.000429	0.00704	CbGeAlD
Estradiol—ABCC10—female reproductive system—skin cancer	0.000428	0.00702	CbGeAlD
Estradiol—SLC22A3—mammalian vulva—skin cancer	0.000428	0.00701	CbGeAlD
Estradiol—ESR1—epithelium—skin cancer	0.000421	0.00691	CbGeAlD
Estradiol—AR—skin of body—skin cancer	0.000408	0.00669	CbGeAlD
Estradiol—SLCO2B1—female reproductive system—skin cancer	0.000401	0.00658	CbGeAlD
Estradiol—ESR2—head—skin cancer	0.000382	0.00626	CbGeAlD
Estradiol—SLCO1C1—lymph node—skin cancer	0.000376	0.00617	CbGeAlD
Estradiol—AR—mammalian vulva—skin cancer	0.000372	0.00611	CbGeAlD
Estradiol—SLC22A3—female reproductive system—skin cancer	0.000366	0.00601	CbGeAlD
Estradiol—CYP1B1—lymphoid tissue—skin cancer	0.000349	0.00572	CbGeAlD
Estradiol—ABCB1—blood vessel—skin cancer	0.000342	0.00561	CbGeAlD
Estradiol—CYP1B1—female reproductive system—skin cancer	0.000337	0.00552	CbGeAlD
Estradiol—SLCO2B1—head—skin cancer	0.000335	0.00549	CbGeAlD
Estradiol—AR—lymphoid tissue—skin cancer	0.000331	0.00542	CbGeAlD
Estradiol—ESR1—lymphoid tissue—skin cancer	0.000325	0.00532	CbGeAlD
Estradiol—CYP1A1—epithelium—skin cancer	0.00032	0.00525	CbGeAlD
Estradiol—SLC22A1—head—skin cancer	0.00032	0.00525	CbGeAlD
Estradiol—AR—female reproductive system—skin cancer	0.000319	0.00523	CbGeAlD
Estradiol—ESR1—female reproductive system—skin cancer	0.000313	0.00513	CbGeAlD
Estradiol—SLCO1A2—head—skin cancer	0.000308	0.00506	CbGeAlD
Estradiol—SLC22A3—head—skin cancer	0.000306	0.00502	CbGeAlD
Estradiol—CYP1A1—skin of body—skin cancer	0.000305	0.005	CbGeAlD
Estradiol—SLCO4A1—lymph node—skin cancer	0.000301	0.00494	CbGeAlD
Estradiol—SLC22A8—head—skin cancer	0.000294	0.00483	CbGeAlD
Estradiol—ABCG2—mammalian vulva—skin cancer	0.000293	0.0048	CbGeAlD
Estradiol—CYP1B1—head—skin cancer	0.000281	0.00461	CbGeAlD
Estradiol—CYP1A1—mammalian vulva—skin cancer	0.000278	0.00456	CbGeAlD
Estradiol—ESR2—lymph node—skin cancer	0.000267	0.00438	CbGeAlD
Estradiol—AR—head—skin cancer	0.000266	0.00437	CbGeAlD
Estradiol—ESR1—head—skin cancer	0.000262	0.00429	CbGeAlD
Estradiol—CYP2C8—female reproductive system—skin cancer	0.000258	0.00423	CbGeAlD
Estradiol—AOX1—lymph node—skin cancer	0.000257	0.00422	CbGeAlD
Estradiol—ABCC10—lymph node—skin cancer	0.00025	0.00411	CbGeAlD
Estradiol—CYP1A1—female reproductive system—skin cancer	0.000238	0.0039	CbGeAlD
Estradiol—SLCO2B1—lymph node—skin cancer	0.000235	0.00385	CbGeAlD
Estradiol—CYP2C9—female reproductive system—skin cancer	0.000229	0.00376	CbGeAlD
Estradiol—ALB—lymph node—skin cancer	0.000215	0.00352	CbGeAlD
Estradiol—SLC22A3—lymph node—skin cancer	0.000214	0.00351	CbGeAlD
Estradiol—CYP1A1—head—skin cancer	0.000199	0.00326	CbGeAlD
Estradiol—CYP1B1—lymph node—skin cancer	0.000197	0.00323	CbGeAlD
Estradiol—AR—lymph node—skin cancer	0.000187	0.00306	CbGeAlD
Estradiol—ESR1—lymph node—skin cancer	0.000183	0.003	CbGeAlD
Estradiol—CYP3A4—female reproductive system—skin cancer	0.000175	0.00286	CbGeAlD
Estradiol—ABCB1—epithelium—skin cancer	0.000166	0.00273	CbGeAlD
Estradiol—ABCG2—lymph node—skin cancer	0.000147	0.0024	CbGeAlD
Estradiol—ABCB1—mammalian vulva—skin cancer	0.000144	0.00237	CbGeAlD
Estradiol—Abdominal pain—Imiquimod—skin cancer	0.000144	0.000666	CcSEcCtD
Estradiol—Eye disorder—Temozolomide—skin cancer	0.000143	0.000664	CcSEcCtD
Estradiol—Tinnitus—Temozolomide—skin cancer	0.000143	0.000663	CcSEcCtD
Estradiol—Malaise—Bleomycin—skin cancer	0.000143	0.000662	CcSEcCtD
Estradiol—Flushing—Temozolomide—skin cancer	0.000142	0.00066	CcSEcCtD
Estradiol—Cardiac disorder—Temozolomide—skin cancer	0.000142	0.00066	CcSEcCtD
Estradiol—Haemoglobin—Fluorouracil—skin cancer	0.000142	0.000658	CcSEcCtD
Estradiol—Rhinitis—Fluorouracil—skin cancer	0.000142	0.000657	CcSEcCtD
Estradiol—Haemorrhage—Fluorouracil—skin cancer	0.000141	0.000655	CcSEcCtD
Estradiol—Dizziness—Vemurafenib—skin cancer	0.000141	0.000653	CcSEcCtD
Estradiol—Hypoaesthesia—Fluorouracil—skin cancer	0.000141	0.000652	CcSEcCtD
Estradiol—Pharyngitis—Fluorouracil—skin cancer	0.00014	0.00065	CcSEcCtD
Estradiol—Angiopathy—Temozolomide—skin cancer	0.000139	0.000645	CcSEcCtD
Estradiol—CYP1A1—lymph node—skin cancer	0.000139	0.00228	CbGeAlD
Estradiol—Immune system disorder—Temozolomide—skin cancer	0.000139	0.000642	CcSEcCtD
Estradiol—Mediastinal disorder—Temozolomide—skin cancer	0.000138	0.000641	CcSEcCtD
Estradiol—Cough—Bleomycin—skin cancer	0.000138	0.00064	CcSEcCtD
Estradiol—Chills—Temozolomide—skin cancer	0.000138	0.000638	CcSEcCtD
Estradiol—Ill-defined disorder—Dactinomycin—skin cancer	0.000137	0.000635	CcSEcCtD
Estradiol—Liver function test abnormal—Docetaxel—skin cancer	0.000136	0.000631	CcSEcCtD
Estradiol—Vomiting—Vemurafenib—skin cancer	0.000136	0.000628	CcSEcCtD
Estradiol—Alopecia—Temozolomide—skin cancer	0.000136	0.000628	CcSEcCtD
Estradiol—Dry skin—Docetaxel—skin cancer	0.000135	0.000626	CcSEcCtD
Estradiol—Myalgia—Bleomycin—skin cancer	0.000135	0.000625	CcSEcCtD
Estradiol—Chest pain—Bleomycin—skin cancer	0.000135	0.000625	CcSEcCtD
Estradiol—Abdominal pain upper—Docetaxel—skin cancer	0.000135	0.000624	CcSEcCtD
Estradiol—Rash—Vemurafenib—skin cancer	0.000135	0.000623	CcSEcCtD
Estradiol—Mental disorder—Temozolomide—skin cancer	0.000135	0.000623	CcSEcCtD
Estradiol—Dermatitis—Vemurafenib—skin cancer	0.000134	0.000623	CcSEcCtD
Estradiol—Hypersensitivity—Imiquimod—skin cancer	0.000134	0.000621	CcSEcCtD
Estradiol—Headache—Vemurafenib—skin cancer	0.000134	0.000619	CcSEcCtD
Estradiol—Malnutrition—Temozolomide—skin cancer	0.000134	0.000619	CcSEcCtD
Estradiol—Erythema—Temozolomide—skin cancer	0.000134	0.000619	CcSEcCtD
Estradiol—Breast disorder—Docetaxel—skin cancer	0.000133	0.000618	CcSEcCtD
Estradiol—Discomfort—Bleomycin—skin cancer	0.000133	0.000617	CcSEcCtD
Estradiol—Malaise—Dactinomycin—skin cancer	0.000133	0.000617	CcSEcCtD
Estradiol—Cramp muscle—Docetaxel—skin cancer	0.000133	0.000615	CcSEcCtD
Estradiol—Nasopharyngitis—Docetaxel—skin cancer	0.000132	0.000611	CcSEcCtD
Estradiol—Dysgeusia—Temozolomide—skin cancer	0.000131	0.000606	CcSEcCtD
Estradiol—Asthenia—Imiquimod—skin cancer	0.000131	0.000605	CcSEcCtD
Estradiol—Confusional state—Bleomycin—skin cancer	0.00013	0.000604	CcSEcCtD
Estradiol—Alanine aminotransferase increased—Docetaxel—skin cancer	0.00013	0.000603	CcSEcCtD
Estradiol—Anaphylactic shock—Bleomycin—skin cancer	0.000129	0.000599	CcSEcCtD
Estradiol—Oedema—Bleomycin—skin cancer	0.000129	0.000599	CcSEcCtD
Estradiol—Back pain—Temozolomide—skin cancer	0.000129	0.000599	CcSEcCtD
Estradiol—Pruritus—Imiquimod—skin cancer	0.000129	0.000596	CcSEcCtD
Estradiol—Infection—Bleomycin—skin cancer	0.000128	0.000595	CcSEcCtD
Estradiol—ABCB1—lymphoid tissue—skin cancer	0.000128	0.0021	CbGeAlD
Estradiol—Dysphagia—Docetaxel—skin cancer	0.000128	0.000591	CcSEcCtD
Estradiol—Nausea—Vemurafenib—skin cancer	0.000127	0.000587	CcSEcCtD
Estradiol—Myalgia—Dactinomycin—skin cancer	0.000126	0.000582	CcSEcCtD
Estradiol—Bronchospasm—Docetaxel—skin cancer	0.000125	0.000581	CcSEcCtD
Estradiol—Tremor—Temozolomide—skin cancer	0.000125	0.00058	CcSEcCtD
Estradiol—Alopecia—Fluorouracil—skin cancer	0.000125	0.000579	CcSEcCtD
Estradiol—Diarrhoea—Imiquimod—skin cancer	0.000125	0.000577	CcSEcCtD
Estradiol—Discomfort—Dactinomycin—skin cancer	0.000124	0.000576	CcSEcCtD
Estradiol—Ill-defined disorder—Temozolomide—skin cancer	0.000124	0.000574	CcSEcCtD
Estradiol—ABCB1—female reproductive system—skin cancer	0.000124	0.00203	CbGeAlD
Estradiol—Erythema—Fluorouracil—skin cancer	0.000123	0.00057	CcSEcCtD
Estradiol—Agitation—Temozolomide—skin cancer	0.000123	0.000569	CcSEcCtD
Estradiol—Angioedema—Temozolomide—skin cancer	0.000122	0.000565	CcSEcCtD
Estradiol—Oedema—Dactinomycin—skin cancer	0.000121	0.000558	CcSEcCtD
Estradiol—Malaise—Temozolomide—skin cancer	0.000121	0.000558	CcSEcCtD
Estradiol—Dizziness—Imiquimod—skin cancer	0.00012	0.000557	CcSEcCtD
Estradiol—Vertigo—Temozolomide—skin cancer	0.00012	0.000556	CcSEcCtD
Estradiol—Infection—Dactinomycin—skin cancer	0.00012	0.000555	CcSEcCtD
Estradiol—Palpitations—Temozolomide—skin cancer	0.000118	0.000547	CcSEcCtD
Estradiol—Musculoskeletal discomfort—Bleomycin—skin cancer	0.000118	0.000545	CcSEcCtD
Estradiol—Cough—Temozolomide—skin cancer	0.000117	0.00054	CcSEcCtD
Estradiol—Paraesthesia—Bleomycin—skin cancer	0.000116	0.000538	CcSEcCtD
Estradiol—Weight increased—Docetaxel—skin cancer	0.000116	0.000538	CcSEcCtD
Estradiol—Vomiting—Imiquimod—skin cancer	0.000116	0.000536	CcSEcCtD
Estradiol—Weight decreased—Docetaxel—skin cancer	0.000115	0.000534	CcSEcCtD
Estradiol—Hypertension—Temozolomide—skin cancer	0.000115	0.000534	CcSEcCtD
Estradiol—Dyspnoea—Bleomycin—skin cancer	0.000115	0.000534	CcSEcCtD
Estradiol—Rash—Imiquimod—skin cancer	0.000115	0.000531	CcSEcCtD
Estradiol—Dermatitis—Imiquimod—skin cancer	0.000115	0.000531	CcSEcCtD
Estradiol—Pneumonia—Docetaxel—skin cancer	0.000114	0.00053	CcSEcCtD
Estradiol—Headache—Imiquimod—skin cancer	0.000114	0.000528	CcSEcCtD
Estradiol—Myalgia—Temozolomide—skin cancer	0.000114	0.000527	CcSEcCtD
Estradiol—Arthralgia—Temozolomide—skin cancer	0.000114	0.000527	CcSEcCtD
Estradiol—Infestation—Docetaxel—skin cancer	0.000114	0.000527	CcSEcCtD
Estradiol—Infestation NOS—Docetaxel—skin cancer	0.000114	0.000527	CcSEcCtD
Estradiol—Anxiety—Temozolomide—skin cancer	0.000113	0.000525	CcSEcCtD
Estradiol—Unspecified disorder of skin and subcutaneous tissue—Temozolomide—skin cancer	0.000113	0.000523	CcSEcCtD
Estradiol—Discomfort—Temozolomide—skin cancer	0.000112	0.000521	CcSEcCtD
Estradiol—Decreased appetite—Bleomycin—skin cancer	0.000112	0.00052	CcSEcCtD
Estradiol—Acute coronary syndrome—Docetaxel—skin cancer	0.000112	0.000519	CcSEcCtD
Estradiol—Neuropathy peripheral—Docetaxel—skin cancer	0.000111	0.000516	CcSEcCtD
Estradiol—Myocardial infarction—Docetaxel—skin cancer	0.000111	0.000516	CcSEcCtD
Estradiol—Dry mouth—Temozolomide—skin cancer	0.000111	0.000515	CcSEcCtD
Estradiol—Jaundice—Docetaxel—skin cancer	0.000111	0.000513	CcSEcCtD
Estradiol—Pain—Bleomycin—skin cancer	0.000111	0.000512	CcSEcCtD
Estradiol—Conjunctivitis—Docetaxel—skin cancer	0.000111	0.000512	CcSEcCtD
Estradiol—Confusional state—Temozolomide—skin cancer	0.00011	0.000509	CcSEcCtD
Estradiol—Musculoskeletal discomfort—Dactinomycin—skin cancer	0.00011	0.000509	CcSEcCtD
Estradiol—Anaphylactic shock—Temozolomide—skin cancer	0.000109	0.000505	CcSEcCtD
Estradiol—Oedema—Temozolomide—skin cancer	0.000109	0.000505	CcSEcCtD
Estradiol—Infection—Temozolomide—skin cancer	0.000108	0.000502	CcSEcCtD
Estradiol—Nausea—Imiquimod—skin cancer	0.000108	0.000501	CcSEcCtD
Estradiol—Hepatobiliary disease—Docetaxel—skin cancer	0.000108	0.000498	CcSEcCtD
Estradiol—Epistaxis—Docetaxel—skin cancer	0.000107	0.000497	CcSEcCtD
Estradiol—Nervous system disorder—Temozolomide—skin cancer	0.000107	0.000495	CcSEcCtD
Estradiol—Feeling abnormal—Bleomycin—skin cancer	0.000107	0.000493	CcSEcCtD
Estradiol—Skin disorder—Temozolomide—skin cancer	0.000106	0.000491	CcSEcCtD
Estradiol—Hyperhidrosis—Temozolomide—skin cancer	0.000105	0.000488	CcSEcCtD
Estradiol—Myalgia—Fluorouracil—skin cancer	0.000105	0.000485	CcSEcCtD
Estradiol—Chest pain—Fluorouracil—skin cancer	0.000105	0.000485	CcSEcCtD
Estradiol—Decreased appetite—Dactinomycin—skin cancer	0.000105	0.000485	CcSEcCtD
Estradiol—Fatigue—Dactinomycin—skin cancer	0.000104	0.000481	CcSEcCtD
Estradiol—Discomfort—Fluorouracil—skin cancer	0.000104	0.00048	CcSEcCtD
Estradiol—ABCB1—head—skin cancer	0.000103	0.00169	CbGeAlD
Estradiol—Pain—Dactinomycin—skin cancer	0.000103	0.000478	CcSEcCtD
Estradiol—Urticaria—Bleomycin—skin cancer	0.000103	0.000476	CcSEcCtD
Estradiol—Haemoglobin—Docetaxel—skin cancer	0.000103	0.000475	CcSEcCtD
Estradiol—Rhinitis—Docetaxel—skin cancer	0.000102	0.000474	CcSEcCtD
Estradiol—Body temperature increased—Bleomycin—skin cancer	0.000102	0.000473	CcSEcCtD
Estradiol—Haemorrhage—Docetaxel—skin cancer	0.000102	0.000473	CcSEcCtD
Estradiol—Hepatitis—Docetaxel—skin cancer	0.000102	0.000473	CcSEcCtD
Estradiol—Hypoaesthesia—Docetaxel—skin cancer	0.000102	0.00047	CcSEcCtD
Estradiol—Confusional state—Fluorouracil—skin cancer	0.000101	0.000469	CcSEcCtD
Estradiol—Pharyngitis—Docetaxel—skin cancer	0.000101	0.000469	CcSEcCtD
Estradiol—Urinary tract disorder—Docetaxel—skin cancer	0.000101	0.000467	CcSEcCtD
Estradiol—Oedema peripheral—Docetaxel—skin cancer	0.000101	0.000466	CcSEcCtD
Estradiol—Anaphylactic shock—Fluorouracil—skin cancer	0.0001	0.000465	CcSEcCtD
Estradiol—Oedema—Fluorouracil—skin cancer	0.0001	0.000465	CcSEcCtD
Estradiol—Connective tissue disorder—Docetaxel—skin cancer	0.0001	0.000465	CcSEcCtD
Estradiol—Urethral disorder—Docetaxel—skin cancer	0.0001	0.000463	CcSEcCtD
Estradiol—Infection—Fluorouracil—skin cancer	9.98e-05	0.000462	CcSEcCtD
Estradiol—Feeling abnormal—Dactinomycin—skin cancer	9.94e-05	0.00046	CcSEcCtD
Estradiol—Musculoskeletal discomfort—Temozolomide—skin cancer	9.94e-05	0.00046	CcSEcCtD
Estradiol—Insomnia—Temozolomide—skin cancer	9.87e-05	0.000457	CcSEcCtD
Estradiol—Gastrointestinal pain—Dactinomycin—skin cancer	9.86e-05	0.000457	CcSEcCtD
Estradiol—Nervous system disorder—Fluorouracil—skin cancer	9.86e-05	0.000456	CcSEcCtD
Estradiol—Visual impairment—Docetaxel—skin cancer	9.84e-05	0.000456	CcSEcCtD
Estradiol—Tachycardia—Fluorouracil—skin cancer	9.81e-05	0.000454	CcSEcCtD
Estradiol—Paraesthesia—Temozolomide—skin cancer	9.79e-05	0.000454	CcSEcCtD
Estradiol—Dyspnoea—Temozolomide—skin cancer	9.72e-05	0.00045	CcSEcCtD
Estradiol—Somnolence—Temozolomide—skin cancer	9.7e-05	0.000449	CcSEcCtD
Estradiol—Erythema multiforme—Docetaxel—skin cancer	9.65e-05	0.000447	CcSEcCtD
Estradiol—Dyspepsia—Temozolomide—skin cancer	9.6e-05	0.000445	CcSEcCtD
Estradiol—Eye disorder—Docetaxel—skin cancer	9.54e-05	0.000442	CcSEcCtD
Estradiol—Abdominal pain—Dactinomycin—skin cancer	9.53e-05	0.000441	CcSEcCtD
Estradiol—Body temperature increased—Dactinomycin—skin cancer	9.53e-05	0.000441	CcSEcCtD
Estradiol—Hypersensitivity—Bleomycin—skin cancer	9.53e-05	0.000441	CcSEcCtD
Estradiol—Decreased appetite—Temozolomide—skin cancer	9.48e-05	0.000439	CcSEcCtD
Estradiol—Cardiac disorder—Docetaxel—skin cancer	9.48e-05	0.000439	CcSEcCtD
Estradiol—Flushing—Docetaxel—skin cancer	9.48e-05	0.000439	CcSEcCtD
Estradiol—Gastrointestinal disorder—Temozolomide—skin cancer	9.42e-05	0.000436	CcSEcCtD
Estradiol—Fatigue—Temozolomide—skin cancer	9.4e-05	0.000435	CcSEcCtD
Estradiol—Pain—Temozolomide—skin cancer	9.33e-05	0.000432	CcSEcCtD
Estradiol—Constipation—Temozolomide—skin cancer	9.33e-05	0.000432	CcSEcCtD
Estradiol—Asthenia—Bleomycin—skin cancer	9.28e-05	0.00043	CcSEcCtD
Estradiol—Angiopathy—Docetaxel—skin cancer	9.26e-05	0.000429	CcSEcCtD
Estradiol—Immune system disorder—Docetaxel—skin cancer	9.22e-05	0.000427	CcSEcCtD
Estradiol—Mediastinal disorder—Docetaxel—skin cancer	9.2e-05	0.000426	CcSEcCtD
Estradiol—Chills—Docetaxel—skin cancer	9.16e-05	0.000424	CcSEcCtD
Estradiol—Musculoskeletal discomfort—Fluorouracil—skin cancer	9.16e-05	0.000424	CcSEcCtD
Estradiol—Pruritus—Bleomycin—skin cancer	9.15e-05	0.000424	CcSEcCtD
Estradiol—Insomnia—Fluorouracil—skin cancer	9.09e-05	0.000421	CcSEcCtD
Estradiol—Paraesthesia—Fluorouracil—skin cancer	9.02e-05	0.000418	CcSEcCtD
Estradiol—Alopecia—Docetaxel—skin cancer	9.02e-05	0.000418	CcSEcCtD
Estradiol—Feeling abnormal—Temozolomide—skin cancer	8.99e-05	0.000416	CcSEcCtD
Estradiol—Dyspnoea—Fluorouracil—skin cancer	8.96e-05	0.000415	CcSEcCtD
Estradiol—Mental disorder—Docetaxel—skin cancer	8.94e-05	0.000414	CcSEcCtD
Estradiol—Somnolence—Fluorouracil—skin cancer	8.93e-05	0.000414	CcSEcCtD
Estradiol—Gastrointestinal pain—Temozolomide—skin cancer	8.92e-05	0.000413	CcSEcCtD
Estradiol—Erythema—Docetaxel—skin cancer	8.89e-05	0.000412	CcSEcCtD
Estradiol—Malnutrition—Docetaxel—skin cancer	8.89e-05	0.000412	CcSEcCtD
Estradiol—Hypersensitivity—Dactinomycin—skin cancer	8.88e-05	0.000411	CcSEcCtD
Estradiol—Dyspepsia—Fluorouracil—skin cancer	8.85e-05	0.00041	CcSEcCtD
Estradiol—Decreased appetite—Fluorouracil—skin cancer	8.74e-05	0.000405	CcSEcCtD
Estradiol—Dysgeusia—Docetaxel—skin cancer	8.7e-05	0.000403	CcSEcCtD
Estradiol—Gastrointestinal disorder—Fluorouracil—skin cancer	8.68e-05	0.000402	CcSEcCtD
Estradiol—Urticaria—Temozolomide—skin cancer	8.66e-05	0.000401	CcSEcCtD
Estradiol—Asthenia—Dactinomycin—skin cancer	8.65e-05	0.000401	CcSEcCtD
Estradiol—Body temperature increased—Temozolomide—skin cancer	8.62e-05	0.000399	CcSEcCtD
Estradiol—Abdominal pain—Temozolomide—skin cancer	8.62e-05	0.000399	CcSEcCtD
Estradiol—Back pain—Docetaxel—skin cancer	8.6e-05	0.000398	CcSEcCtD
Estradiol—Pain—Fluorouracil—skin cancer	8.59e-05	0.000398	CcSEcCtD
Estradiol—Muscle spasms—Docetaxel—skin cancer	8.54e-05	0.000396	CcSEcCtD
Estradiol—Feeling abnormal—Fluorouracil—skin cancer	8.28e-05	0.000383	CcSEcCtD
Estradiol—Diarrhoea—Dactinomycin—skin cancer	8.25e-05	0.000382	CcSEcCtD
Estradiol—Vomiting—Bleomycin—skin cancer	8.22e-05	0.000381	CcSEcCtD
Estradiol—Rash—Bleomycin—skin cancer	8.15e-05	0.000378	CcSEcCtD
Estradiol—Dermatitis—Bleomycin—skin cancer	8.15e-05	0.000377	CcSEcCtD
Estradiol—Hypersensitivity—Temozolomide—skin cancer	8.04e-05	0.000372	CcSEcCtD
Estradiol—Urticaria—Fluorouracil—skin cancer	7.98e-05	0.00037	CcSEcCtD
Estradiol—Syncope—Docetaxel—skin cancer	7.97e-05	0.000369	CcSEcCtD
Estradiol—Body temperature increased—Fluorouracil—skin cancer	7.94e-05	0.000368	CcSEcCtD
Estradiol—Palpitations—Docetaxel—skin cancer	7.85e-05	0.000364	CcSEcCtD
Estradiol—Asthenia—Temozolomide—skin cancer	7.83e-05	0.000362	CcSEcCtD
Estradiol—Loss of consciousness—Docetaxel—skin cancer	7.81e-05	0.000362	CcSEcCtD
Estradiol—Cough—Docetaxel—skin cancer	7.76e-05	0.000359	CcSEcCtD
Estradiol—Pruritus—Temozolomide—skin cancer	7.72e-05	0.000357	CcSEcCtD
Estradiol—Nausea—Bleomycin—skin cancer	7.68e-05	0.000356	CcSEcCtD
Estradiol—Hypertension—Docetaxel—skin cancer	7.67e-05	0.000355	CcSEcCtD
Estradiol—Vomiting—Dactinomycin—skin cancer	7.67e-05	0.000355	CcSEcCtD
Estradiol—Rash—Dactinomycin—skin cancer	7.6e-05	0.000352	CcSEcCtD
Estradiol—Chest pain—Docetaxel—skin cancer	7.57e-05	0.00035	CcSEcCtD
Estradiol—Myalgia—Docetaxel—skin cancer	7.57e-05	0.00035	CcSEcCtD
Estradiol—Arthralgia—Docetaxel—skin cancer	7.57e-05	0.00035	CcSEcCtD
Estradiol—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—skin cancer	7.51e-05	0.000348	CcSEcCtD
Estradiol—Diarrhoea—Temozolomide—skin cancer	7.46e-05	0.000346	CcSEcCtD
Estradiol—Hypersensitivity—Fluorouracil—skin cancer	7.4e-05	0.000343	CcSEcCtD
Estradiol—Dry mouth—Docetaxel—skin cancer	7.4e-05	0.000343	CcSEcCtD
Estradiol—Confusional state—Docetaxel—skin cancer	7.31e-05	0.000339	CcSEcCtD
Estradiol—Oedema—Docetaxel—skin cancer	7.25e-05	0.000336	CcSEcCtD
Estradiol—Anaphylactic shock—Docetaxel—skin cancer	7.25e-05	0.000336	CcSEcCtD
Estradiol—ABCB1—lymph node—skin cancer	7.23e-05	0.00119	CbGeAlD
Estradiol—Dizziness—Temozolomide—skin cancer	7.21e-05	0.000334	CcSEcCtD
Estradiol—Infection—Docetaxel—skin cancer	7.21e-05	0.000334	CcSEcCtD
Estradiol—Nausea—Dactinomycin—skin cancer	7.16e-05	0.000332	CcSEcCtD
Estradiol—Shock—Docetaxel—skin cancer	7.14e-05	0.00033	CcSEcCtD
Estradiol—Nervous system disorder—Docetaxel—skin cancer	7.11e-05	0.000329	CcSEcCtD
Estradiol—Pruritus—Fluorouracil—skin cancer	7.11e-05	0.000329	CcSEcCtD
Estradiol—Tachycardia—Docetaxel—skin cancer	7.08e-05	0.000328	CcSEcCtD
Estradiol—Skin disorder—Docetaxel—skin cancer	7.05e-05	0.000326	CcSEcCtD
Estradiol—Vomiting—Temozolomide—skin cancer	6.93e-05	0.000321	CcSEcCtD
Estradiol—Rash—Temozolomide—skin cancer	6.88e-05	0.000318	CcSEcCtD
Estradiol—Diarrhoea—Fluorouracil—skin cancer	6.88e-05	0.000318	CcSEcCtD
Estradiol—Dermatitis—Temozolomide—skin cancer	6.87e-05	0.000318	CcSEcCtD
Estradiol—Headache—Temozolomide—skin cancer	6.83e-05	0.000316	CcSEcCtD
Estradiol—Dizziness—Fluorouracil—skin cancer	6.65e-05	0.000308	CcSEcCtD
Estradiol—Musculoskeletal discomfort—Docetaxel—skin cancer	6.61e-05	0.000306	CcSEcCtD
Estradiol—Insomnia—Docetaxel—skin cancer	6.56e-05	0.000304	CcSEcCtD
Estradiol—Paraesthesia—Docetaxel—skin cancer	6.51e-05	0.000302	CcSEcCtD
Estradiol—Nausea—Temozolomide—skin cancer	6.48e-05	0.0003	CcSEcCtD
Estradiol—Dyspnoea—Docetaxel—skin cancer	6.47e-05	0.000299	CcSEcCtD
Estradiol—Somnolence—Docetaxel—skin cancer	6.45e-05	0.000299	CcSEcCtD
Estradiol—Vomiting—Fluorouracil—skin cancer	6.39e-05	0.000296	CcSEcCtD
Estradiol—Dyspepsia—Docetaxel—skin cancer	6.38e-05	0.000296	CcSEcCtD
Estradiol—Rash—Fluorouracil—skin cancer	6.34e-05	0.000293	CcSEcCtD
Estradiol—Dermatitis—Fluorouracil—skin cancer	6.33e-05	0.000293	CcSEcCtD
Estradiol—Decreased appetite—Docetaxel—skin cancer	6.31e-05	0.000292	CcSEcCtD
Estradiol—Headache—Fluorouracil—skin cancer	6.3e-05	0.000292	CcSEcCtD
Estradiol—Gastrointestinal disorder—Docetaxel—skin cancer	6.26e-05	0.00029	CcSEcCtD
Estradiol—Fatigue—Docetaxel—skin cancer	6.25e-05	0.00029	CcSEcCtD
Estradiol—Constipation—Docetaxel—skin cancer	6.2e-05	0.000287	CcSEcCtD
Estradiol—Pain—Docetaxel—skin cancer	6.2e-05	0.000287	CcSEcCtD
Estradiol—Feeling abnormal—Docetaxel—skin cancer	5.98e-05	0.000277	CcSEcCtD
Estradiol—Nausea—Fluorouracil—skin cancer	5.97e-05	0.000276	CcSEcCtD
Estradiol—Gastrointestinal pain—Docetaxel—skin cancer	5.93e-05	0.000275	CcSEcCtD
Estradiol—Abdominal pain—Docetaxel—skin cancer	5.73e-05	0.000266	CcSEcCtD
Estradiol—Body temperature increased—Docetaxel—skin cancer	5.73e-05	0.000266	CcSEcCtD
Estradiol—ALB—SLC-mediated transmembrane transport—SLC12A2—skin cancer	5.53e-05	0.00198	CbGpPWpGaD
Estradiol—ESR1—Signaling mediated by p38-alpha and p38-beta—TP53—skin cancer	5.46e-05	0.00195	CbGpPWpGaD
Estradiol—SLCO1B1—Metabolism of lipids and lipoproteins—PLIN2—skin cancer	5.45e-05	0.00195	CbGpPWpGaD
Estradiol—ESR1—Plasma membrane estrogen receptor signaling—KRAS—skin cancer	5.41e-05	0.00193	CbGpPWpGaD
Estradiol—Hypersensitivity—Docetaxel—skin cancer	5.34e-05	0.000247	CcSEcCtD
Estradiol—CYP1B1—Aryl Hydrocarbon Receptor—KRAS—skin cancer	5.31e-05	0.0019	CbGpPWpGaD
Estradiol—Asthenia—Docetaxel—skin cancer	5.2e-05	0.000241	CcSEcCtD
Estradiol—AR—Integrated Breast Cancer Pathway—CDK4—skin cancer	5.17e-05	0.00185	CbGpPWpGaD
Estradiol—Pruritus—Docetaxel—skin cancer	5.13e-05	0.000238	CcSEcCtD
Estradiol—AOX1—Metabolism—PLIN2—skin cancer	4.96e-05	0.00177	CbGpPWpGaD
Estradiol—Diarrhoea—Docetaxel—skin cancer	4.96e-05	0.00023	CcSEcCtD
Estradiol—GPER1—Signaling Pathways—FOXO4—skin cancer	4.95e-05	0.00177	CbGpPWpGaD
Estradiol—ESR1—Aryl Hydrocarbon Receptor—KRAS—skin cancer	4.93e-05	0.00176	CbGpPWpGaD
Estradiol—SLCO1B1—Transmembrane transport of small molecules—SLC12A2—skin cancer	4.92e-05	0.00176	CbGpPWpGaD
Estradiol—CYP1A1—Aryl Hydrocarbon Receptor—PTGS2—skin cancer	4.88e-05	0.00174	CbGpPWpGaD
Estradiol—Dizziness—Docetaxel—skin cancer	4.8e-05	0.000222	CcSEcCtD
Estradiol—AOX1—Disease—CSPG4—skin cancer	4.78e-05	0.00171	CbGpPWpGaD
Estradiol—ESR2—Integrated Pancreatic Cancer Pathway—PTGS2—skin cancer	4.68e-05	0.00167	CbGpPWpGaD
Estradiol—ESR1—LKB1 signaling events—TP53—skin cancer	4.63e-05	0.00165	CbGpPWpGaD
Estradiol—Vomiting—Docetaxel—skin cancer	4.61e-05	0.000214	CcSEcCtD
Estradiol—ESR1—Plasma membrane estrogen receptor signaling—HRAS—skin cancer	4.6e-05	0.00164	CbGpPWpGaD
Estradiol—AR—Integrated Breast Cancer Pathway—BRAF—skin cancer	4.57e-05	0.00164	CbGpPWpGaD
Estradiol—Rash—Docetaxel—skin cancer	4.57e-05	0.000212	CcSEcCtD
Estradiol—Dermatitis—Docetaxel—skin cancer	4.57e-05	0.000212	CcSEcCtD
Estradiol—CYP1A1—Arachidonic acid metabolism—PTGS2—skin cancer	4.56e-05	0.00163	CbGpPWpGaD
Estradiol—ABCB1—HIF-1-alpha transcription factor network—TERT—skin cancer	4.56e-05	0.00163	CbGpPWpGaD
Estradiol—ABCG2—Transmembrane transport of small molecules—SLC12A2—skin cancer	4.55e-05	0.00163	CbGpPWpGaD
Estradiol—Headache—Docetaxel—skin cancer	4.54e-05	0.00021	CcSEcCtD
Estradiol—CYP1B1—Aryl Hydrocarbon Receptor—HRAS—skin cancer	4.51e-05	0.00161	CbGpPWpGaD
Estradiol—SLC22A2—Transmembrane transport of small molecules—SLC12A2—skin cancer	4.5e-05	0.00161	CbGpPWpGaD
Estradiol—Nausea—Docetaxel—skin cancer	4.31e-05	0.000199	CcSEcCtD
Estradiol—AR—Integrated Pancreatic Cancer Pathway—CDK4—skin cancer	4.28e-05	0.00153	CbGpPWpGaD
Estradiol—SLC22A1—Transmembrane transport of small molecules—SLC12A2—skin cancer	4.2e-05	0.0015	CbGpPWpGaD
Estradiol—ESR1—Aryl Hydrocarbon Receptor—HRAS—skin cancer	4.19e-05	0.0015	CbGpPWpGaD
Estradiol—ESR1—Signaling Pathways—RHOU—skin cancer	4.18e-05	0.0015	CbGpPWpGaD
Estradiol—CYP2C8—Arachidonic acid metabolism—PTGS2—skin cancer	4.18e-05	0.0015	CbGpPWpGaD
Estradiol—AOX1—Metabolism—CSPG4—skin cancer	4e-05	0.00143	CbGpPWpGaD
Estradiol—ESR1—Integrated Breast Cancer Pathway—CDK4—skin cancer	3.98e-05	0.00142	CbGpPWpGaD
Estradiol—ESRRA—Metabolism—ENO2—skin cancer	3.92e-05	0.0014	CbGpPWpGaD
Estradiol—CYP1A1—Aryl Hydrocarbon Receptor—NRAS—skin cancer	3.8e-05	0.00136	CbGpPWpGaD
Estradiol—CYP2C19—Arachidonic acid metabolism—PTGS2—skin cancer	3.73e-05	0.00134	CbGpPWpGaD
Estradiol—SLCO1B3—Metabolism—PLIN2—skin cancer	3.61e-05	0.00129	CbGpPWpGaD
Estradiol—ABCB1—Integrated Pancreatic Cancer Pathway—SHH—skin cancer	3.58e-05	0.00128	CbGpPWpGaD
Estradiol—SLC22A3—Metabolism—PLIN2—skin cancer	3.55e-05	0.00127	CbGpPWpGaD
Estradiol—ESR1—Integrated Breast Cancer Pathway—BRAF—skin cancer	3.52e-05	0.00126	CbGpPWpGaD
Estradiol—CYP1A1—Metabolism of lipids and lipoproteins—PLIN2—skin cancer	3.42e-05	0.00122	CbGpPWpGaD
Estradiol—CYP2C9—Arachidonic acid metabolism—PTGS2—skin cancer	3.41e-05	0.00122	CbGpPWpGaD
Estradiol—ABCB1—Integrated Pancreatic Cancer Pathway—SMO—skin cancer	3.4e-05	0.00121	CbGpPWpGaD
Estradiol—GPER1—Signaling Pathways—TERT—skin cancer	3.31e-05	0.00118	CbGpPWpGaD
Estradiol—ESR1—Integrated Pancreatic Cancer Pathway—CDK4—skin cancer	3.3e-05	0.00118	CbGpPWpGaD
Estradiol—ESR1—ATF-2 transcription factor network—IL6—skin cancer	3.29e-05	0.00118	CbGpPWpGaD
Estradiol—CYP1A1—Aryl Hydrocarbon Receptor—KRAS—skin cancer	3.27e-05	0.00117	CbGpPWpGaD
Estradiol—AOX1—Disease—SHH—skin cancer	3.25e-05	0.00116	CbGpPWpGaD
Estradiol—AOX1—Disease—ENO2—skin cancer	3.25e-05	0.00116	CbGpPWpGaD
Estradiol—CYP2C8—Metabolism of lipids and lipoproteins—PLIN2—skin cancer	3.13e-05	0.00112	CbGpPWpGaD
Estradiol—ESR1—AP-1 transcription factor network—TP53—skin cancer	3.13e-05	0.00112	CbGpPWpGaD
Estradiol—ESR2—Integrated Pancreatic Cancer Pathway—KRAS—skin cancer	3.13e-05	0.00112	CbGpPWpGaD
Estradiol—ALB—Metabolism of lipids and lipoproteins—PLIN2—skin cancer	3.12e-05	0.00111	CbGpPWpGaD
Estradiol—CYP1A2—Aryl Hydrocarbon Receptor—PTGS2—skin cancer	3.11e-05	0.00111	CbGpPWpGaD
Estradiol—ESRRA—Metabolism of lipids and lipoproteins—PTGS2—skin cancer	3.07e-05	0.0011	CbGpPWpGaD
Estradiol—AR—Integrated Pancreatic Cancer Pathway—PTGS2—skin cancer	3.06e-05	0.00109	CbGpPWpGaD
Estradiol—ESR2—SIDS Susceptibility Pathways—IL6—skin cancer	3e-05	0.00107	CbGpPWpGaD
Estradiol—ESRRA—Gene Expression—ERCC2—skin cancer	2.93e-05	0.00105	CbGpPWpGaD
Estradiol—SLCO1B3—Metabolism—CSPG4—skin cancer	2.91e-05	0.00104	CbGpPWpGaD
Estradiol—CYP1A2—Arachidonic acid metabolism—PTGS2—skin cancer	2.91e-05	0.00104	CbGpPWpGaD
Estradiol—ESR1—AP-1 transcription factor network—IL6—skin cancer	2.87e-05	0.00103	CbGpPWpGaD
Estradiol—SLC22A3—Metabolism—CSPG4—skin cancer	2.86e-05	0.00102	CbGpPWpGaD
Estradiol—SLCO1A2—Metabolism—PLIN2—skin cancer	2.84e-05	0.00102	CbGpPWpGaD
Estradiol—ESR1—Leptin signaling pathway—HRAS—skin cancer	2.84e-05	0.00101	CbGpPWpGaD
Estradiol—ALB—Transmembrane transport of small molecules—SLC12A2—skin cancer	2.81e-05	0.001	CbGpPWpGaD
Estradiol—CYP2C19—Metabolism of lipids and lipoproteins—PLIN2—skin cancer	2.8e-05	0.001	CbGpPWpGaD
Estradiol—GPER1—Signaling by GPCR—NRAS—skin cancer	2.79e-05	0.000996	CbGpPWpGaD
Estradiol—ESR2—Integrated Pancreatic Cancer Pathway—TP53—skin cancer	2.78e-05	0.000995	CbGpPWpGaD
Estradiol—CYP1A1—Aryl Hydrocarbon Receptor—HRAS—skin cancer	2.78e-05	0.000993	CbGpPWpGaD
Estradiol—SLC22A2—Transmission across Chemical Synapses—BRAF—skin cancer	2.73e-05	0.000974	CbGpPWpGaD
Estradiol—AOX1—Metabolism—ENO2—skin cancer	2.72e-05	0.000972	CbGpPWpGaD
Estradiol—NR1I2—Gene Expression—ERCC2—skin cancer	2.65e-05	0.000948	CbGpPWpGaD
Estradiol—UGT1A1—Metabolism—PLIN2—skin cancer	2.65e-05	0.000948	CbGpPWpGaD
Estradiol—AOX1—Disease—FOXO4—skin cancer	2.65e-05	0.000946	CbGpPWpGaD
Estradiol—ALB—Selenium Micronutrient Network—PTGS2—skin cancer	2.65e-05	0.000946	CbGpPWpGaD
Estradiol—GPER1—Signaling Pathways—BRAF—skin cancer	2.62e-05	0.000937	CbGpPWpGaD
Estradiol—CYP2C9—Metabolism of lipids and lipoproteins—PLIN2—skin cancer	2.55e-05	0.000912	CbGpPWpGaD
Estradiol—SLC22A1—Transmission across Chemical Synapses—BRAF—skin cancer	2.54e-05	0.000908	CbGpPWpGaD
Estradiol—AR—Integrated Breast Cancer Pathway—KRAS—skin cancer	2.47e-05	0.000884	CbGpPWpGaD
Estradiol—CYP1B1—Metabolism—PLIN2—skin cancer	2.47e-05	0.000884	CbGpPWpGaD
Estradiol—ABCB1—Transmembrane transport of small molecules—SLC12A2—skin cancer	2.46e-05	0.00088	CbGpPWpGaD
Estradiol—SLCO1B1—Metabolism—PLIN2—skin cancer	2.43e-05	0.000868	CbGpPWpGaD
Estradiol—CYP1A2—Aryl Hydrocarbon Receptor—NRAS—skin cancer	2.42e-05	0.000865	CbGpPWpGaD
Estradiol—GPER1—Signaling by GPCR—KRAS—skin cancer	2.4e-05	0.000858	CbGpPWpGaD
Estradiol—ESR1—Integrated Pancreatic Cancer Pathway—PTGS2—skin cancer	2.36e-05	0.000843	CbGpPWpGaD
Estradiol—SLCO1A2—Metabolism—CSPG4—skin cancer	2.29e-05	0.000818	CbGpPWpGaD
Estradiol—ESRRA—Metabolism—ERCC2—skin cancer	2.28e-05	0.000815	CbGpPWpGaD
Estradiol—ABCG2—Metabolism—PLIN2—skin cancer	2.25e-05	0.000804	CbGpPWpGaD
Estradiol—ALB—Vitamin B12 Metabolism—IL6—skin cancer	2.23e-05	0.000798	CbGpPWpGaD
Estradiol—CYP3A7—Metabolism—PLIN2—skin cancer	2.23e-05	0.000797	CbGpPWpGaD
Estradiol—SLC22A2—Metabolism—PLIN2—skin cancer	2.23e-05	0.000796	CbGpPWpGaD
Estradiol—ESR1—Signaling by ERBB4—NRAS—skin cancer	2.2e-05	0.000787	CbGpPWpGaD
Estradiol—AR—Integrated Breast Cancer Pathway—TP53—skin cancer	2.2e-05	0.000786	CbGpPWpGaD
Estradiol—CYP1A2—Metabolism of lipids and lipoproteins—PLIN2—skin cancer	2.18e-05	0.000779	CbGpPWpGaD
Estradiol—UGT1A1—Metabolism—CSPG4—skin cancer	2.14e-05	0.000764	CbGpPWpGaD
Estradiol—SLC22A2—Neuronal System—BRAF—skin cancer	2.09e-05	0.000746	CbGpPWpGaD
Estradiol—CYP1A2—Aryl Hydrocarbon Receptor—KRAS—skin cancer	2.08e-05	0.000745	CbGpPWpGaD
Estradiol—SLC22A1—Metabolism—PLIN2—skin cancer	2.07e-05	0.000742	CbGpPWpGaD
Estradiol—AR—Integrated Pancreatic Cancer Pathway—KRAS—skin cancer	2.05e-05	0.000733	CbGpPWpGaD
Estradiol—ESR1—Signaling Pathways—PTCH2—skin cancer	2.04e-05	0.000731	CbGpPWpGaD
Estradiol—GPER1—Signaling by GPCR—HRAS—skin cancer	2.04e-05	0.000729	CbGpPWpGaD
Estradiol—CYP1B1—Metabolism—CSPG4—skin cancer	1.99e-05	0.000712	CbGpPWpGaD
Estradiol—ALB—Folate Metabolism—TP53—skin cancer	1.98e-05	0.000709	CbGpPWpGaD
Estradiol—SLCO1B3—Metabolism—ENO2—skin cancer	1.98e-05	0.000708	CbGpPWpGaD
Estradiol—AR—SIDS Susceptibility Pathways—IL6—skin cancer	1.96e-05	0.000701	CbGpPWpGaD
Estradiol—SLCO1B1—Metabolism—CSPG4—skin cancer	1.96e-05	0.0007	CbGpPWpGaD
Estradiol—GPER1—Signaling by GPCR—IL6—skin cancer	1.95e-05	0.000698	CbGpPWpGaD
Estradiol—SLC22A1—Neuronal System—BRAF—skin cancer	1.95e-05	0.000696	CbGpPWpGaD
Estradiol—SLC22A3—Metabolism—ENO2—skin cancer	1.94e-05	0.000695	CbGpPWpGaD
Estradiol—ESR1—Integrated Breast Cancer Pathway—KRAS—skin cancer	1.91e-05	0.000681	CbGpPWpGaD
Estradiol—ESR1—Signaling by ERBB4—KRAS—skin cancer	1.9e-05	0.000678	CbGpPWpGaD
Estradiol—AOX1—Disease—ERCC2—skin cancer	1.89e-05	0.000674	CbGpPWpGaD
Estradiol—ESR2—Gene Expression—ERCC2—skin cancer	1.87e-05	0.000667	CbGpPWpGaD
Estradiol—AR—Integrated Pancreatic Cancer Pathway—TP53—skin cancer	1.82e-05	0.000651	CbGpPWpGaD
Estradiol—ALB—Folate Metabolism—IL6—skin cancer	1.82e-05	0.000649	CbGpPWpGaD
Estradiol—ABCG2—Metabolism—CSPG4—skin cancer	1.81e-05	0.000648	CbGpPWpGaD
Estradiol—CYP3A7—Metabolism—CSPG4—skin cancer	1.8e-05	0.000642	CbGpPWpGaD
Estradiol—SLC22A2—Metabolism—CSPG4—skin cancer	1.79e-05	0.000641	CbGpPWpGaD
Estradiol—CYP1A2—Aryl Hydrocarbon Receptor—HRAS—skin cancer	1.77e-05	0.000633	CbGpPWpGaD
Estradiol—AOX1—Disease—TERT—skin cancer	1.77e-05	0.000632	CbGpPWpGaD
Estradiol—ABCB1—Integrated Pancreatic Cancer Pathway—CDK4—skin cancer	1.75e-05	0.000624	CbGpPWpGaD
Estradiol—ESR1—Integrated Breast Cancer Pathway—TP53—skin cancer	1.69e-05	0.000606	CbGpPWpGaD
Estradiol—SLC22A1—Metabolism—CSPG4—skin cancer	1.67e-05	0.000598	CbGpPWpGaD
Estradiol—GPER1—Signaling Pathways—NRAS—skin cancer	1.65e-05	0.000589	CbGpPWpGaD
Estradiol—ESR1—Signaling by ERBB4—HRAS—skin cancer	1.61e-05	0.000576	CbGpPWpGaD
Estradiol—CYP3A5—Metabolism—PLIN2—skin cancer	1.61e-05	0.000576	CbGpPWpGaD
Estradiol—AOX1—Metabolism—ERCC2—skin cancer	1.58e-05	0.000565	CbGpPWpGaD
Estradiol—ESR1—Integrated Pancreatic Cancer Pathway—KRAS—skin cancer	1.58e-05	0.000565	CbGpPWpGaD
Estradiol—SLCO1A2—Metabolism—ENO2—skin cancer	1.56e-05	0.000556	CbGpPWpGaD
Estradiol—SLCO1B3—Metabolism of lipids and lipoproteins—PTGS2—skin cancer	1.55e-05	0.000554	CbGpPWpGaD
Estradiol—ESR1—Signaling Pathways—GLI2—skin cancer	1.55e-05	0.000554	CbGpPWpGaD
Estradiol—ESR1—Signaling by ERBB4—IL6—skin cancer	1.54e-05	0.000551	CbGpPWpGaD
Estradiol—CYP1A1—Metabolism—PLIN2—skin cancer	1.52e-05	0.000544	CbGpPWpGaD
Estradiol—ESR1—Signaling Pathways—MC1R—skin cancer	1.48e-05	0.000528	CbGpPWpGaD
Estradiol—ESR1—Signaling Pathways—GLI1—skin cancer	1.46e-05	0.000521	CbGpPWpGaD
Estradiol—UGT1A1—Metabolism—ENO2—skin cancer	1.45e-05	0.000519	CbGpPWpGaD
Estradiol—ALB—Selenium Micronutrient Network—IL6—skin cancer	1.44e-05	0.000516	CbGpPWpGaD
Estradiol—GPER1—Signaling Pathways—KRAS—skin cancer	1.42e-05	0.000507	CbGpPWpGaD
Estradiol—ESR1—Integrated Pancreatic Cancer Pathway—TP53—skin cancer	1.4e-05	0.000502	CbGpPWpGaD
Estradiol—AOX1—Disease—BRAF—skin cancer	1.4e-05	0.000501	CbGpPWpGaD
Estradiol—CYP2C8—Metabolism—PLIN2—skin cancer	1.4e-05	0.000499	CbGpPWpGaD
Estradiol—ALB—Metabolism—PLIN2—skin cancer	1.39e-05	0.000496	CbGpPWpGaD
Estradiol—ESR1—Signaling Pathways—SUFU—skin cancer	1.38e-05	0.000494	CbGpPWpGaD
Estradiol—ESRRA—Metabolism—PTGS2—skin cancer	1.37e-05	0.000489	CbGpPWpGaD
Estradiol—CYP1B1—Metabolism—ENO2—skin cancer	1.35e-05	0.000484	CbGpPWpGaD
Estradiol—SLCO1B1—Metabolism—ENO2—skin cancer	1.33e-05	0.000476	CbGpPWpGaD
Estradiol—CYP3A5—Metabolism—CSPG4—skin cancer	1.3e-05	0.000464	CbGpPWpGaD
Estradiol—GPER1—Signaling Pathways—TP53—skin cancer	1.26e-05	0.00045	CbGpPWpGaD
Estradiol—SLC22A2—Transmission across Chemical Synapses—HRAS—skin cancer	1.25e-05	0.000448	CbGpPWpGaD
Estradiol—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—skin cancer	1.25e-05	0.000446	CbGpPWpGaD
Estradiol—CYP2C19—Metabolism—PLIN2—skin cancer	1.25e-05	0.000445	CbGpPWpGaD
Estradiol—ABCG2—Metabolism—ENO2—skin cancer	1.23e-05	0.00044	CbGpPWpGaD
Estradiol—CYP1A1—Metabolism—CSPG4—skin cancer	1.23e-05	0.000439	CbGpPWpGaD
Estradiol—CYP3A7—Metabolism—ENO2—skin cancer	1.22e-05	0.000437	CbGpPWpGaD
Estradiol—AR—Gene Expression—ERCC2—skin cancer	1.22e-05	0.000437	CbGpPWpGaD
Estradiol—SLC22A2—Metabolism—ENO2—skin cancer	1.22e-05	0.000436	CbGpPWpGaD
Estradiol—SLCO1A2—Metabolism of lipids and lipoproteins—PTGS2—skin cancer	1.22e-05	0.000435	CbGpPWpGaD
Estradiol—ABCB1—Metabolism—PLIN2—skin cancer	1.22e-05	0.000435	CbGpPWpGaD
Estradiol—GPER1—Signaling Pathways—HRAS—skin cancer	1.2e-05	0.000431	CbGpPWpGaD
Estradiol—SLC22A1—Transmission across Chemical Synapses—HRAS—skin cancer	1.17e-05	0.000418	CbGpPWpGaD
Estradiol—GPER1—Signaling Pathways—IL6—skin cancer	1.15e-05	0.000412	CbGpPWpGaD
Estradiol—SLCO1B3—Metabolism—ERCC2—skin cancer	1.15e-05	0.000411	CbGpPWpGaD
Estradiol—SLC22A1—Metabolism—ENO2—skin cancer	1.14e-05	0.000406	CbGpPWpGaD
Estradiol—CYP2C9—Metabolism—PLIN2—skin cancer	1.14e-05	0.000406	CbGpPWpGaD
Estradiol—AOX1—Disease—PTGS2—skin cancer	1.13e-05	0.000404	CbGpPWpGaD
Estradiol—SLC22A3—Metabolism—ERCC2—skin cancer	1.13e-05	0.000404	CbGpPWpGaD
Estradiol—CYP2C8—Metabolism—CSPG4—skin cancer	1.12e-05	0.000402	CbGpPWpGaD
Estradiol—ALB—Metabolism—CSPG4—skin cancer	1.12e-05	0.0004	CbGpPWpGaD
Estradiol—CYP1B1—Metabolism of lipids and lipoproteins—PTGS2—skin cancer	1.06e-05	0.000379	CbGpPWpGaD
Estradiol—ESR1—Signaling Pathways—SHH—skin cancer	1.05e-05	0.000376	CbGpPWpGaD
Estradiol—ESR1—Signaling Pathways—RASA1—skin cancer	1.05e-05	0.000374	CbGpPWpGaD
Estradiol—SLCO1B1—Metabolism of lipids and lipoproteins—PTGS2—skin cancer	1.04e-05	0.000372	CbGpPWpGaD
Estradiol—CYP2C19—Metabolism—CSPG4—skin cancer	1e-05	0.000359	CbGpPWpGaD
Estradiol—ESR1—Signaling Pathways—PTCH1—skin cancer	9.98e-06	0.000357	CbGpPWpGaD
Estradiol—ESR1—Signaling Pathways—SMO—skin cancer	9.98e-06	0.000357	CbGpPWpGaD
Estradiol—ABCB1—Metabolism—CSPG4—skin cancer	9.8e-06	0.00035	CbGpPWpGaD
Estradiol—ESR1—Signaling Pathways—PTGER4—skin cancer	9.72e-06	0.000347	CbGpPWpGaD
Estradiol—CYP1A2—Metabolism—PLIN2—skin cancer	9.71e-06	0.000347	CbGpPWpGaD
Estradiol—SLC22A2—Neuronal System—HRAS—skin cancer	9.6e-06	0.000343	CbGpPWpGaD
Estradiol—AOX1—Metabolism—PTGS2—skin cancer	9.47e-06	0.000339	CbGpPWpGaD
Estradiol—ESR1—Gene Expression—ERCC2—skin cancer	9.41e-06	0.000336	CbGpPWpGaD
Estradiol—CYP2C9—Metabolism—CSPG4—skin cancer	9.16e-06	0.000327	CbGpPWpGaD
Estradiol—SLCO1A2—Metabolism—ERCC2—skin cancer	9.04e-06	0.000323	CbGpPWpGaD
Estradiol—SLC22A1—Neuronal System—HRAS—skin cancer	8.95e-06	0.00032	CbGpPWpGaD
Estradiol—CYP3A5—Metabolism—ENO2—skin cancer	8.83e-06	0.000316	CbGpPWpGaD
Estradiol—AOX1—Disease—NRAS—skin cancer	8.8e-06	0.000315	CbGpPWpGaD
Estradiol—ESR1—Signaling Pathways—FOXO4—skin cancer	8.58e-06	0.000307	CbGpPWpGaD
Estradiol—UGT1A1—Metabolism—ERCC2—skin cancer	8.44e-06	0.000302	CbGpPWpGaD
Estradiol—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—skin cancer	8.36e-06	0.000299	CbGpPWpGaD
Estradiol—CYP1A1—Metabolism—ENO2—skin cancer	8.34e-06	0.000298	CbGpPWpGaD
Estradiol—CYP1B1—Metabolism—ERCC2—skin cancer	7.87e-06	0.000281	CbGpPWpGaD
Estradiol—CYP1A2—Metabolism—CSPG4—skin cancer	7.82e-06	0.00028	CbGpPWpGaD
Estradiol—SLCO1B1—Metabolism—ERCC2—skin cancer	7.73e-06	0.000276	CbGpPWpGaD
Estradiol—CYP2C8—Metabolism—ENO2—skin cancer	7.65e-06	0.000273	CbGpPWpGaD
Estradiol—ALB—Metabolism—ENO2—skin cancer	7.6e-06	0.000272	CbGpPWpGaD
Estradiol—AOX1—Disease—KRAS—skin cancer	7.57e-06	0.000271	CbGpPWpGaD
Estradiol—CYP3A4—Metabolism—PLIN2—skin cancer	7.49e-06	0.000268	CbGpPWpGaD
Estradiol—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—skin cancer	7.43e-06	0.000265	CbGpPWpGaD
Estradiol—ABCG2—Metabolism—ERCC2—skin cancer	7.16e-06	0.000256	CbGpPWpGaD
Estradiol—CYP3A7—Metabolism—ERCC2—skin cancer	7.09e-06	0.000254	CbGpPWpGaD
Estradiol—SLC22A2—Metabolism—ERCC2—skin cancer	7.08e-06	0.000253	CbGpPWpGaD
Estradiol—SLCO1B3—Metabolism—PTGS2—skin cancer	6.9e-06	0.000247	CbGpPWpGaD
Estradiol—CYP2C19—Metabolism—ENO2—skin cancer	6.83e-06	0.000244	CbGpPWpGaD
Estradiol—SLC22A3—Metabolism—PTGS2—skin cancer	6.77e-06	0.000242	CbGpPWpGaD
Estradiol—ABCB1—Metabolism—ENO2—skin cancer	6.66e-06	0.000238	CbGpPWpGaD
Estradiol—SLC22A1—Metabolism—ERCC2—skin cancer	6.6e-06	0.000236	CbGpPWpGaD
Estradiol—CYP1A1—Metabolism of lipids and lipoproteins—PTGS2—skin cancer	6.52e-06	0.000233	CbGpPWpGaD
Estradiol—AOX1—Disease—HRAS—skin cancer	6.44e-06	0.00023	CbGpPWpGaD
Estradiol—CYP2C9—Metabolism—ENO2—skin cancer	6.22e-06	0.000222	CbGpPWpGaD
Estradiol—AOX1—Disease—IL6—skin cancer	6.16e-06	0.00022	CbGpPWpGaD
Estradiol—CYP3A4—Metabolism—CSPG4—skin cancer	6.04e-06	0.000216	CbGpPWpGaD
Estradiol—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—skin cancer	5.98e-06	0.000214	CbGpPWpGaD
Estradiol—ALB—Metabolism of lipids and lipoproteins—PTGS2—skin cancer	5.95e-06	0.000213	CbGpPWpGaD
Estradiol—ESR1—Signaling Pathways—TERT—skin cancer	5.73e-06	0.000205	CbGpPWpGaD
Estradiol—SLCO1A2—Metabolism—PTGS2—skin cancer	5.42e-06	0.000194	CbGpPWpGaD
Estradiol—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—skin cancer	5.34e-06	0.000191	CbGpPWpGaD
Estradiol—CYP1A2—Metabolism—ENO2—skin cancer	5.32e-06	0.00019	CbGpPWpGaD
Estradiol—CYP3A5—Metabolism—ERCC2—skin cancer	5.13e-06	0.000183	CbGpPWpGaD
Estradiol—ALB—Hemostasis—NRAS—skin cancer	5.08e-06	0.000182	CbGpPWpGaD
Estradiol—UGT1A1—Metabolism—PTGS2—skin cancer	5.06e-06	0.000181	CbGpPWpGaD
Estradiol—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—skin cancer	4.87e-06	0.000174	CbGpPWpGaD
Estradiol—CYP1A1—Metabolism—ERCC2—skin cancer	4.84e-06	0.000173	CbGpPWpGaD
Estradiol—CYP1B1—Metabolism—PTGS2—skin cancer	4.72e-06	0.000169	CbGpPWpGaD
Estradiol—SLCO1B1—Metabolism—PTGS2—skin cancer	4.63e-06	0.000166	CbGpPWpGaD
Estradiol—ESR1—Signaling Pathways—BRAF—skin cancer	4.54e-06	0.000162	CbGpPWpGaD
Estradiol—CYP2C8—Metabolism—ERCC2—skin cancer	4.44e-06	0.000159	CbGpPWpGaD
Estradiol—ALB—Metabolism—ERCC2—skin cancer	4.42e-06	0.000158	CbGpPWpGaD
Estradiol—ALB—Hemostasis—KRAS—skin cancer	4.37e-06	0.000156	CbGpPWpGaD
Estradiol—ABCG2—Metabolism—PTGS2—skin cancer	4.29e-06	0.000153	CbGpPWpGaD
Estradiol—CYP3A7—Metabolism—PTGS2—skin cancer	4.25e-06	0.000152	CbGpPWpGaD
Estradiol—SLC22A2—Metabolism—PTGS2—skin cancer	4.25e-06	0.000152	CbGpPWpGaD
Estradiol—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—skin cancer	4.16e-06	0.000149	CbGpPWpGaD
Estradiol—CYP3A4—Metabolism—ENO2—skin cancer	4.1e-06	0.000147	CbGpPWpGaD
Estradiol—CYP2C19—Metabolism—ERCC2—skin cancer	3.96e-06	0.000142	CbGpPWpGaD
Estradiol—SLC22A1—Metabolism—PTGS2—skin cancer	3.96e-06	0.000142	CbGpPWpGaD
Estradiol—ALB—Hemostasis—TP53—skin cancer	3.89e-06	0.000139	CbGpPWpGaD
Estradiol—ABCB1—Metabolism—ERCC2—skin cancer	3.87e-06	0.000138	CbGpPWpGaD
Estradiol—ALB—Hemostasis—HRAS—skin cancer	3.72e-06	0.000133	CbGpPWpGaD
Estradiol—CYP2C9—Metabolism—ERCC2—skin cancer	3.61e-06	0.000129	CbGpPWpGaD
Estradiol—CYP1A2—Metabolism—ERCC2—skin cancer	3.09e-06	0.00011	CbGpPWpGaD
Estradiol—CYP3A5—Metabolism—PTGS2—skin cancer	3.07e-06	0.00011	CbGpPWpGaD
Estradiol—CYP1A1—Metabolism—PTGS2—skin cancer	2.91e-06	0.000104	CbGpPWpGaD
Estradiol—ESR1—Signaling Pathways—NRAS—skin cancer	2.85e-06	0.000102	CbGpPWpGaD
Estradiol—CYP2C8—Metabolism—PTGS2—skin cancer	2.66e-06	9.52e-05	CbGpPWpGaD
Estradiol—ALB—Metabolism—PTGS2—skin cancer	2.65e-06	9.47e-05	CbGpPWpGaD
Estradiol—ESR1—Signaling Pathways—KRAS—skin cancer	2.46e-06	8.78e-05	CbGpPWpGaD
Estradiol—CYP3A4—Metabolism—ERCC2—skin cancer	2.38e-06	8.52e-05	CbGpPWpGaD
Estradiol—CYP2C19—Metabolism—PTGS2—skin cancer	2.38e-06	8.5e-05	CbGpPWpGaD
Estradiol—ABCB1—Metabolism—PTGS2—skin cancer	2.32e-06	8.29e-05	CbGpPWpGaD
Estradiol—ESR1—Signaling Pathways—TP53—skin cancer	2.18e-06	7.8e-05	CbGpPWpGaD
Estradiol—CYP2C9—Metabolism—PTGS2—skin cancer	2.17e-06	7.75e-05	CbGpPWpGaD
Estradiol—ESR1—Signaling Pathways—HRAS—skin cancer	2.09e-06	7.46e-05	CbGpPWpGaD
Estradiol—ESR1—Signaling Pathways—IL6—skin cancer	2e-06	7.14e-05	CbGpPWpGaD
Estradiol—CYP1A2—Metabolism—PTGS2—skin cancer	1.85e-06	6.62e-05	CbGpPWpGaD
Estradiol—CYP3A4—Metabolism—PTGS2—skin cancer	1.43e-06	5.11e-05	CbGpPWpGaD
